ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYAL..................................................JJDIM360 Ver 1.28 (29 Oct 2014) - 2999001/01967191CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120160720W173deBibliographieenBibliographyfrBibliographieEP08156397.5199912172008051620081009enenen112667 P19981217US2016072020162920080910200837201605182016202015120120160720201629A61K 9/16 20060101AFI20151016BHEP deOrale Methylphenidat-Formulierungen mit kontrollierter/veränderter FreisetzungenControlled/modified release oral methylphenidate formulationsfrFormulations orales de methylphenidate a liberation regulee/modifieeWO-A-97/03673WO-A-98/23263US-A- 5 286 493US-A- 5 837 284DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 30 October 1997 (1997-10-30), ERRAMOUSPE, JOHN ET AL: "Effect on dissolution from halving methylphenidate extended -release tablets" XP002489744 retrieved from STN Database accession no. 1997:686114 & ANNALS OF PHARMACOTHERAPY , 31(10), 1123-1126 CODEN: APHRER; ISSN: 1060-0280, 1997,99967438.5114008819991217Goldenheim, Paul D.16 Hillside AveCambridge, MA 02140-3616USSackler, Richard S.25 Windrose WayGreenwich, CT 06830USKrishnamurthy, Thinnayam N.575 Granite CourtPickering Ontario L1W 3W8CADarke, Andrew575 Granite CourtPickering Ontario L1W 3W8CAOshlack, Benjamin350 South Ocean Boulevard Apt. 3DBoca Raton, FL 33432USEURO-CELTIQUE S.A.101592004E 10103 / HG1, rue Jean Piret2350 LuxembourgLUGlas, Holger100051941Maiwald Patentanwalts GmbH Elisenhof Elisenstrasse 380335 MünchenDEATBECHCYDEDKESFIFRGBGRIEITLILUMCNLPTSEAL20080516LT20080516LV20080516MK20080516RO20080516SI2008051620080910200837